FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
RYHCX
Price
$95.68
Change
-$0.30 (-0.31%)
Updated
Nov 19 closing price
Net Assets
22.76M
Interact to see
Advertisement

FSPHX vs RYHCX

Header iconFSPHX vs RYHCX Comparison
Open Charts FSPHX vs RYHCXBanner chart's image
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
Rydex Health Care C
Price$95.68
Change-$0.30 (-0.31%)
VolumeN/A
Net Assets22.76M
FSPHX vs RYHCX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. RYHCX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and RYHCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. RYHCX (22.8M). FSPHX pays higher dividends than RYHCX: FSPHX (0.02) vs RYHCX (0.00). FSPHX was incepted earlier than RYHCX: FSPHX (44 years) vs RYHCX (25 years). RYHCX (2.43) is less costly to investors than FSPHX (0.63). RYHCX is a more actively managed with annual turnover of: 236.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than RYHCX: FSPHX (0) vs RYHCX (2500). RYHCX annual gain was more profitable for investors over the last year : 9.60 vs. FSPHX (0.02). RYHCX return over 5 years is better than : 5.59 vs. FSPHX (-8.84).
FSPHXRYHCXFSPHX / RYHCX
Total Expense Ratio0.632.3826%
Annual Report Gross Expense Ratio0.632.4326%
Fund Existence44 years25 years-
Gain YTD10.53211.82689%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B22.8M27,263%
Annual Yield % from dividends0.020.00-
Returns for 1 year0.029.600%
Returns for 3 years10.4715.2169%
Returns for 5 years-8.845.59-158%
Returns for 10 years39.3420.37193%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5